Real-time enrollment status for this recurrent mantle cell lymphoma clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 12:09 PM UTC
| NCT Number | NCT07673367 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Mantle Cell Lymphoma |
| Phase | PHASE2 |
| Target Enrollment | 25 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Vanderbilt-Ingram Cancer Center |
| Last Updated on CT.gov | August 17, 2026 (1 week ago) |
As of August 27, 2026: Clinical trial NCT07673367 is currently recruiting participants. This phase2 study for recurrent mantle cell lymphoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Vanderbilt-Ingram Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07673367 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07673367 was last updated 1 week ago (August 17, 2026). HelloStudys verifies this status automatically.